Genexine

Developer of immunotherapeutics for treating orphan diseases, cancers & autoimmune disorders

placeSeongnam-si, Gyeonggi-do, South Korea calendar_todayFounded 2002 language genexine.com

Social engagement

Social engagement: 1.5K social following, 5 posts in the last 12 months — below the industry typical range.

Investor mix

6 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital467%
Private equity233%

Recent activity

12 Nov 2025
Event
Incheon #RNA-Based Therapeutics & Vaccine Summit Asia
7 Jul 2025
Event
5th Annual mRNA-Based Therapeutics Summit
Coming soon